The BB/Wor diabetes-prone rat is an animal model of human insulin-dependent diabetes mellitus. In this model of spontaneous autoimmunity, natural killer cells are candidate cytotoxic effector cells, believed to be the mediators of beta-cell cytolysis in vivo. We therefore studied the effects of an anti-natural killer cell monoclonal antibody on the spontaneous development of diabetes in the BB/Wor rat. BB/Wor diabetes-prone (DP) rats develop spontaneous autoimmune diabetes mellitus between the ages of 50-120 days. Pancreatic beta-cell destruction is the culmination of a cell-mediated immune attack. The morphologic hallmark of beta-cell autoimmunity is a destructive lymphocytic insulitis which immediately precedes the onset of hyperglycaemia. It is characterized by the presence of numerous intra-islet Ia + (dendritic cells and macrophages), CD5 +, and CD8 + cells [1, 2] , and the hyperexpression of MHC class I protein in both endocrine and exocrine cells [3, 4] . We previously reported [5] the prevention of spontaneous diabetes by injections of anti-CD5 or anti-CD8 monoclonal antibodies (MoAbs), and suggested that lymphocytes bearing these cell-surface markers are essential components of the autoimmune attack.
BB/Wor diabetes-prone (DP) rats develop spontaneous autoimmune diabetes mellitus between the ages of 50-120 days. Pancreatic beta-cell destruction is the culmination of a cell-mediated immune attack. The morphologic hallmark of beta-cell autoimmunity is a destructive lymphocytic insulitis which immediately precedes the onset of hyperglycaemia. It is characterized by the presence of numerous intra-islet Ia + (dendritic cells and macrophages), CD5 +, and CD8 + cells [1, 2] , and the hyperexpression of MHC class I protein in both endocrine and exocrine cells [3, 4] . We previously reported [5] the prevention of spontaneous diabetes by injections of anti-CD5 or anti-CD8 monoclonal antibodies (MoAbs), and suggested that lymphocytes bearing these cell-surface markers are essential components of the autoimmune attack.
In the rat, natural killer (NK) cells are phenotypically characterized as expressing 3.2.3, CD8, and asialoganglioside M1 (ASGM1) cell-surface markers, while lacking CD5 antigen. DP rats have very high numbers of CD8 + NK cells (-12 % of peripheral blood mononuclear cells) and a virtual absence of phenotypic and functional CD8 + cytotoxic T lymphocytes (CTL) [6, 7] . The cytotoxic activity of NK (CD8 +/CD5-) cells is also increased [8] , and is responsible for lysing Yac-1 and islet cells in vitro [9, 10] . Furthermore, in vivo treatment of DP rats with anti-CD8 MoAb or ASGM1 anti-serum prevents recurrent diabetes [11, 12] . These observations support a direct role for NK cells in BB/Wor diabetes, However, ASGM1 and CD8 are present on both NK cells and CTL, and are thus not selective NK-cell markers. The recently described MoAb 3.2.3 recognizes a molecule present on rat NK, lymphokine-activated killer, and polymorphonuclear cells, but not T lymphocytes, and selectively depletes NK cells in vivo [13, 14] . With the availability of the 3.2.3 MoAb, we re-evaluated the pathogenic role of NK cells in BB/Wor autoimmune diabetes by the immune elimination of 3.2.3 + cells in vivo.
Materials and methods
Animals. All BB/Wor rats in this study were raised at the University of Massachusetts Medical School and have been inbred for more than 40 generations. DP rats were raised in a viral-antibody free environment and have an incidence of spontaneous diabetes of 75-95 % between the ages of 50 and 120 days, with a mean age at onset orS0 days [15] .
Monoclonal antibodies. OX-6 (anti-Ia), OX-8 (anti-CD8) and OX-19 (anti-CDS) MoAbs were produced by hybridoma celt lines from Dr. A. E Williams and Dr. D. W. Mason (Oxford University, Oxford, UK). The 3.2.3 hybridoma was obtained from Dr. J.C.Hiserodt (Pittsburgh, Pa., USA). The hybridoma cell lines were grown under standard tissue culture conditions, and the undiluted tissue culture supernatants were used for animal injections and flow cytometry.
Experiment protocols. Litters of 25-30-day-old DP rats were randomized into groups and either untreated, or injected i.p. five Representative non-diabetic animals were killed after 4, 5, 8 and 10 weeks of injections for analysis of spleen lymphocytes. Animals were tested for glycosuria three times weekly. Diabetes was diagnosed on the basis of glycosuria (TesTape; Eli Lilly, Indianapolis, Ind., USA) and a blood glucose of 13.9 mmol/1 or more in the tail blood, (Beckman Glucose Analyzer II; Beckman Instruments, Fullerton, Calif., USA). Diabetic animals were killed on the day the diabetes was diagnosed, and the remaining non-diabetic animals were killed at 120 days of age.
Flow cytometry. One and two-colour analysis of peripheral blood lymphocytes was performed as previously described [5] .
Cytotoxicity assays. Yac-1 target cells were labelled with 51Cr
(Amersham Corp., Arlington Heights, III., USA), 0.1 mC/106 cells. Spleens were minced, lysed in 0.15 tool/1 NH4C1, and plated in microtitre plates (flat-bottomed) at effector/target (E/T) ratios of 200:1,100 : 1, 50:1 and 25 : 1 with 104 target cells/well. RPMI 1640 was added to target cells for spontaneous lysis and 1% Nonidet P40 for 100 % lysis determinations. Assays were incubated for 4 h in a 37~ 6.5 % CO2 in air incubator. Plates were centrifuged before harvest, and one-half of the supernatant collected for radioactive counting in a Beckman gamma 5500 counter (Beckman Instruments, Palo Alto, Calif., USA). Spontaneous release was always less than 15%. Percent specific 51Cr release= 100
Morphologic studies. Pancreata were fixed in Bouin's solution and embedded in paraffin. Haematoxylin-eosin stained sections were examined for the presence of lymphocytic insulitis.
Irnrnunohistochemistry. Immunoperoxidase staining of pancreata with cell-type specific MoAbs was performed as previously described on cryostat sections of pancreata frozen in liquid-nitrogencooled isopentane [4] .
Statistical analyses
One-way analyses of variance were used to compare the effects of various treatment regimens on peripheral blood lymphocyte subsets and NK-cell cytotoxic function. Comparison of the incidence of diabetes was performed using a Fisher's exact test. Calculations were performed with an IBM personal computer using SPSSx statistical software (SPSS, Inc., Chicago, Ill., USA).
Results

Effect of MoAb injections on peripheral blood lymphocyte subsets
DP rats were either not treated or injected five times weekly with 3.2.3 or anti-CD8 MoAb-containing tissue culture supernatants from the age of 25-120 days. At multiple time points, peripheral blood samples were obtained from all experimental groups and analysed for lymphocyte cell-surface markers by single and two-colour flow cytometry ( 
Effect of MoAb injections on frequency of diabetes
T h e cumulative incidence of diabetes (at age 120 days) was 84 % (27 of 32) in untreated controls, 73 % (19 of 26) in 3.2,3-treated rats, and 16% (3 of 19) in anti-CD8 treated animals ( Table 2 ). These data show that depletion of 3.2.3 + cells by MoAb injections did not decrease the frequency of diabetes in DP rats. 3.2.3 treatment also did not delay the mean age at onset of diabetes (data not shown). In contrast, anti-CD8 injections significantly (p < 0.01) reduced the incidence of diabetes.
Effect of 3.2.3 M o A b treatment on insulitis
Pancreatic tissue sections from diabetic rats treated with 3.2.3 MoAb were compared with sections from untreated diabetic controls after staining with a panel of cell-type specific MoAbs (Fig.l) . Spontaneous diabetes in the (Fig. 1 a-c and Fig. 2a) . The inflammatory islet infiltrate of animals injected with 3.2.3 MoAb however, contained very few or no 3.2.3 + cells (Fig. 1 f) . In contrast, 3.2.3-treated rats appeared to have normal numbers of Ia + , CD5 + , and CD8 + cells (Fig. i d,e and Fig. 2 b) . These results demonstrate that 3.2.3 MoAb treatment greatly reduced the number of 3.2.3 + NK, but not CD8 + cells, within the islet infiltrate. Both untreated and 3.2.3-treated diabetic rats showed a similarly amplified expression of MHC class I protein in the insulitis lesion and the surrounding exocrine tissue (Fig. 2 c, d ). This is a morphologic hallmark of the autoimmune process in BB/Wor Type i diabetes.
Effect of MoAb injections on spleen NK-cell activity
Levels of splenic NK-cell lysis against Yac-1 targets were compared in non-diabetic animals from all treatment groups (Table 3) . Assays for all groups were performed concurrently, under identical conditions, to facilitate comparisons. Splenic mononuclear leucocytes from untreated DP rats had characteristically high NK lytic activity, and mediated approximately 40 % killing at E/T ratios of 100:1. Both 3.2.3 and anti-CD8-treated rats had significantly lower levels of splenic NK-cell killing at all E/T ratios (p < 0.001) and at all time points tested. The geometric mean lysis of Yac-1 targets at an E/T ratio of 100:1 was 9.4% for 3.2.3-treated rats, and 15.6% for anti-CDS-treated rats. Levels of NK-cell lytic activity in 3.2.3-treated rats were also significantly lower than those in anti-CD8-treated rats at all E/T ratios, and were similar to those seen in the diabetes-resistant (DR) line of BB/Wor rats. Spleen NK-cell killing in DR rats, at an E/T ratio of 100:1, is typically approximately 5 % (data not shown).
Discussion
Chronic treatment of DP rats with 3. The efficacy of anti-CD8 treatment in the prevention of BB/Wor diabetes suggested a cardinal role for CD8-NK cells in the pathogenesis of this autoimmune syndrome [5] . In the lymphopoenic DP rat. CD4 + T-helper cells are markedly reduced and the CD8 + compartment is almost entirely comprised of phenotypic NK cells: 12.6 % CD8+/CD5 vs 0.8 % CD8+/CD5 + cells. DP rats also appear to be entirely lacking in functional CTL [7] . The DR BB/Wor rats double their CD8 +/CD5 + spleen-cell population 1 week post-infection with lymphocytic choriomeningitis virus (LCMV); the CTLs are virus-specific and restricted to the BB/Wor RT1 u haplotype. LCMV-infected DP rats, however, do not generate increased numbers of spleen CTLs or detectable cytotoxic activity to LCMV-infected targets in vitro. DP rats also fail to generate CTL responses to Pichinde and vaccinia viruses [16] . The greater ability of DP spleen cells, as compared to DR BB/Wor spleen ceils, to lyse Yac-1 and islet cells in vitro [9, 10] therefore suggest a direct role for NK cells in spontaneous BB/Wor diabetes.
The results reported here, however, demonstrate that NK cells are not a necessary element of the diabetogenic process: immune elimination of 3.2.3 + NK cells did not prevent or delay the onset of the clinical syndrome. Recently, other investigators reported similar findings after in vivo depletion of 3.2.3 + NK cells in BB/Wor rats [17] . It has previously been reported that anti-CD5 treatment of DP rats completely prevents diabetes and insulitis [5] . Anti-CD5 treatment reduced numbers of both T-helper cells (CD8-/CD5 +) and CTL, but did not have any effect on the levels of phenotypic NK cells. Similarly, an anti-CD2 MoAb (OX-34) prevents spontaneous diabetes in DP rats [18] . OX-34 injections profoundly deplete CD4 + T cells, while sparing both CD8 § NK cells and CTL. The combined data indicate that T lymphocytes, but not NK cells, mediate autoimmune diabetes in the BBFWor rat.
The identity of the cytotoxic effector responsible for beta-cell cytolysis in vivo remains to be determined. Prevention of diabetes by anti-CD8 treatment indicates that the effector cell may be a classic CTL. In the DP rat, CTL are present in low, barely measurable percentages. They appear to be expanded within the insulitis lesion, however, and are present in 3.2.3-treated and NK-cell-depleted diabetic rats. Anti-CDS-treated rats, although protected from diabetes, have widespread islet infiltration, ranging from early-stage insulitis (-64 % of rats), to advanced insulitis (-36 % of rats). Significantly, those animals with early to moderate insulitis have no detectable CD8 + cells within the lesion, while those rats with advanced insulitis have less than 5 % CD8 § cells within the infiltrate (M.Kurrer, A.A.Like, unpublished observation). Anti-CD8-treated rats, however, have normal numbers of islet-infiltrating CD5 + cells and increased numbers of macrophages. The paucity of CD8 + cells in the insulitis lesion of anti-CD8 protected rats suggests that CD8 § CTL's are necessary for beta-cell cytolysis in vivo.
Since rodent beta cells do not express detectable MHC class II antigen [3, 4, 19, 20] , but do express cell-surface MHC class I molecules, a CD8 + CTL is most likely responsible for beta-cell cytolysis in vivo. Islet-cell MHC class I expression is also greatly enhanced during the course of autoimmune insulitis which further supports a cardinal role for CD8 + CTL in BB/Wor diabetes. Although CD4 + T cells appear to be involved in the inductive phase of diabetogenesis [21, 22] , we do not believe that they would serve as the final effector cell in the absence of MHC class II-bearing target cells.
